In cost-effectiveness analyses, models are used typically to synthesize the best available data and/or extrapolate beyond clinical trial data. Ideally, models should be validated both internally and externally. The purpose of this paper is to suggest a test for internal validation of models...

Quality-adjusted life years are valid representations of the preferences of individuals for health outcomes only under a set of restrictive assumptions. One of the key assumptions is additive utility independence (AUI). Recently, Bleichrodt and Filko [Bleichrodt and Filko, 2008. Journal of...

Considerable methodological research has been conducted on handling uncertainty in cost-effectiveness analysis. The current literature suggests the concepts of net health benefits and cost-effectiveness accepta-bility curves to circumvent the technical shortcomings of cost-effectiveness ratio...

In the past, considerable research in gerontology has focused on services provided to seniors. Recently, however, there has a been a growing recognition of the contributions made by seniors to their families, communities and to society. Empirical estimates have been provided by researchers to...

The inclusion of economic evaluations as part of clinical trials has led to concerns about the adequacy of trial sample size to support such analysis. The analytical tool of cost-effectiveness analysis is the incremental cost-effectiveness ratio (ICER), which is compared with a threshold value...

The Major difference between the United States and Canada with respect to health expenditures lies in the degree of centralization of the cost control process.

In this paper, we develop a conceptual framework to describe an individual's preparations for later life. Situated in the life course perspective, this provides a framework that invites a more comprehensive and systematic study of preparations for later life. It describes a dynamic process that...

The demographic shift towards an older population in Canada has led to concerns about the increased share of society's resources required to provide health care, social asistance, public pensions, housing, etc. for this group. Preoccupation with this problem, however, has obscured the fact that...

In this paper we present a general model that enables us to better understand the decision of a patient whether or not to participate in a treatment, and, if so, the optimal timing for the treatment, from his point of view. The model takes into account both "objective information" which...